Corcept Therapeutics Insider Sold Shares Worth $2,906,601, According to a Recent SEC Filing

MT newswire2026/10/06 07:28

03:28 AM EDT, 10/06/2026 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on October 01, 2026, sold 25,000 shares in Corcept Therapeutics (CORT) for $2,906,601. Following the Form 4 filing with the SEC, Maduck has control over a total of 119,655 common shares of the company, with 9,938 shares held directly and 109,717 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000119312526414674/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.